• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大艾伯塔省复杂心脏植入式电子设备感染:基于验证性行政数据的流行病学队列研究。

Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data.

机构信息

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.

出版信息

Infect Control Hosp Epidemiol. 2023 Oct;44(10):1607-1613. doi: 10.1017/ice.2023.48. Epub 2023 May 15.

DOI:10.1017/ice.2023.48
PMID:37183997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10587380/
Abstract

OBJECTIVE

To establish the epidemiology of cardiac implantable electronic device (CIED) infections in Alberta, Canada, using validated administrative data.

DESIGN

Retrospective, population-based cohort study.

SETTING

Alberta Health Services is a province-wide health system that services all of Alberta, Canada.

PARTICIPANTS

Adult patients who underwent first-time CIED implantation or generator replacement in Alberta, Canada, between January 1, 2011, and December 31, 2019.

METHODS

CIED implant patients were identified from the Paceart database. Patients who developed an infection within 1 year of the index procedure were identified through validated administrative data (International Classification of Diseases, Tenth Revision in Canada). Demographic characteristics of patients were summarized. Logistic regression models were used to analyze device type, comorbidities, and demographics associated with infection rates and mortality.

RESULTS

Among 27,830 CIED implants, there were 205 infections (0.74%). Having 2 or more comorbidities was associated with higher infection risk. Generator replacement procedures (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.34-0.84; P = .008), age increase of every 10 years (OR, 0.73; 95% CI, 0.66-0.82; P ≤ .001), and index procedure after 2014 were associated with decreased risk. Comparing the infected to uninfected groups, the hospitalization rates were 2.63 compared to 0.69, and the mortality rates were 10.73% compared to 3.49%, respectively (P < .001).

CONCLUSIONS

There is a slightly lower overall rate of CIED infections Alberta, Canada compared to previously described epidemiology. Implants after 2014, and generator replacements showed a decreased burden of infection. Patients with younger age, and 2 or more comorbidities are at greatest risk of CIED infection. The burden of hospitalization and mortality is substantially higher in infected patients.

摘要

目的

利用验证后的行政数据,确定加拿大艾伯塔省心脏植入式电子设备(CIED)感染的流行病学情况。

设计

回顾性、基于人群的队列研究。

设置

艾伯塔省卫生服务局是一个覆盖全省的卫生系统,为加拿大艾伯塔省的所有人提供服务。

参与者

2011 年 1 月 1 日至 2019 年 12 月 31 日期间,在加拿大艾伯塔省接受首次 CIED 植入或更换的成年患者。

方法

从 Paceart 数据库中确定 CIED 植入患者。通过验证后的行政数据(加拿大第十版国际疾病分类)确定索引手术后 1 年内发生感染的患者。总结患者的人口统计学特征。使用逻辑回归模型分析与感染率和死亡率相关的设备类型、合并症和人口统计学特征。

结果

在 27830 例 CIED 植入中,有 205 例(0.74%)发生感染。患有 2 种或更多种合并症与更高的感染风险相关。与感染风险相关的因素包括更换为发生器(比值比[OR],0.55;95%置信区间[CI],0.34-0.84;P=0.008)、年龄每增加 10 岁(OR,0.73;95%CI,0.66-0.82;P≤0.001)和 2014 年后进行的索引手术。与未感染组相比,感染组的住院率为 2.63 比 0.69,死亡率为 10.73%比 3.49%(P<0.001)。

结论

与之前描述的流行病学情况相比,加拿大艾伯塔省的 CIED 感染总发生率略低。2014 年后植入的设备和更换的发生器显示出感染负担降低。年龄较小和患有 2 种或更多种合并症的患者感染 CIED 的风险最大。感染患者的住院和死亡率负担明显更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/214d/10587380/1672da1df877/S0899823X2300048X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/214d/10587380/1672da1df877/S0899823X2300048X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/214d/10587380/1672da1df877/S0899823X2300048X_fig1.jpg

相似文献

1
Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data.加拿大艾伯塔省复杂心脏植入式电子设备感染:基于验证性行政数据的流行病学队列研究。
Infect Control Hosp Epidemiol. 2023 Oct;44(10):1607-1613. doi: 10.1017/ice.2023.48. Epub 2023 May 15.
2
Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.美国心脏植入式电子设备感染的流行病学:基于人群的队列研究。
Heart Rhythm. 2020 Jul;17(7):1125-1131. doi: 10.1016/j.hrthm.2020.02.012. Epub 2020 Feb 20.
3
Factors associated with cardiac implantable electronic device-related infections, New South Wales, 2016-21: a retrospective cohort study.与心脏植入式电子设备相关感染相关的因素,新南威尔士州,2016-21:一项回顾性队列研究。
Med J Aust. 2024 Jun 3;220(10):510-516. doi: 10.5694/mja2.52302. Epub 2024 May 6.
4
The predictors and economic burden of early-, mid- and late-onset cardiac implantable electronic device infections: a retrospective cohort study in Ontario, Canada.加拿大安大略省回顾性队列研究:早、中、晚期心脏植入式电子设备感染的预测因素和经济负担。
Clin Microbiol Infect. 2020 Feb;26(2):255.e1-255.e6. doi: 10.1016/j.cmi.2019.02.009. Epub 2019 Feb 22.
5
Cardiac surgery in patients with cardiac implantable electronic devices and risk of device infections: a nationwide nested case-control study.心脏植入式电子设备患者的心脏手术与器械感染风险:一项全国性巢式病例对照研究。
J Interv Card Electrophysiol. 2023 Jun;66(4):897-904. doi: 10.1007/s10840-022-01236-7. Epub 2022 May 2.
6
Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.心血管植入式电子设备植入术后感染及相关费用:一项全国性队列研究。
Europace. 2018 Dec 1;20(12):1974-1980. doi: 10.1093/europace/eux387.
7
Increased long-term mortality in patients with cardiovascular implantable electronic device infections.心血管植入式电子设备感染患者的长期死亡率增加。
Pacing Clin Electrophysiol. 2015 Feb;38(2):231-9. doi: 10.1111/pace.12518. Epub 2014 Sep 21.
8
Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.三十年来心血管植入式电子设备感染的趋势:一项基于人群的研究。
JACC Clin Electrophysiol. 2019 Sep;5(9):1071-1080. doi: 10.1016/j.jacep.2019.06.016. Epub 2019 Aug 28.
9
Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.一种用于确定心脏植入式电子设备感染风险的新型评分系统的提案。
Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):806-812. doi: 10.1016/j.rec.2018.09.003. Epub 2018 Oct 16.
10
Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.纤维囊清创术在心脏植入式电子设备感染风险中的作用:更换发生器时。
J Interv Card Electrophysiol. 2020 Jun;58(1):113-118. doi: 10.1007/s10840-019-00581-4. Epub 2019 Jun 21.

引用本文的文献

1
Cost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review.术中抗菌包膜预防心脏植入式设备相关感染的成本效益:一项系统评价
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf121.
2
Rates of post procedural prophylactic antibiotic use following cardiac implantable electronic device insertion and the impact on surgical site infections in Alberta, Canada.加拿大艾伯塔省心脏植入式电子设备植入术后预防性抗生素的使用比率及其对手术部位感染的影响。
Antimicrob Resist Infect Control. 2024 Dec 18;13(1):147. doi: 10.1186/s13756-024-01512-3.
3

本文引用的文献

1
Validating administrative data to identify complex surgical site infections following cardiac implantable electronic device implantation: a comparison of traditional methods and machine learning.验证行政数据以识别心脏植入式电子设备植入术后的复杂手术部位感染:传统方法与机器学习的比较。
Antimicrob Resist Infect Control. 2022 Nov 10;11(1):138. doi: 10.1186/s13756-022-01174-z.
2
Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.心脏植入式电子设备感染的流行病学:发生率和危险因素。
Europace. 2021 Jun 23;23(23 Suppl 4):iv3-iv10. doi: 10.1093/europace/euab042.
3
Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
Microbiology of cardiac implantable electronic device infections in Calgary, Canada.
加拿大卡尔加里心脏植入式电子设备感染的微生物学研究
Antimicrob Steward Healthc Epidemiol. 2024 Jan 25;4(1):e9. doi: 10.1017/ash.2024.9. eCollection 2024.
4
New advances in management and treatment of cardiac implantable electronic devices infections.心脏植入式电子设备感染的管理和治疗新进展。
Infection. 2024 Apr;52(2):323-336. doi: 10.1007/s15010-023-02130-8. Epub 2023 Nov 24.
美国心脏植入式电子设备感染的流行病学:基于人群的队列研究。
Heart Rhythm. 2020 Jul;17(7):1125-1131. doi: 10.1016/j.hrthm.2020.02.012. Epub 2020 Feb 20.
4
Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.心脏植入式电子设备感染的危险因素。
J Am Coll Cardiol. 2019 Dec 10;74(23):2845-2854. doi: 10.1016/j.jacc.2019.09.060.
5
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.抗菌包膜预防心脏植入式电子设备感染。
N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17.
6
The predictors and economic burden of early-, mid- and late-onset cardiac implantable electronic device infections: a retrospective cohort study in Ontario, Canada.加拿大安大略省回顾性队列研究:早、中、晚期心脏植入式电子设备感染的预测因素和经济负担。
Clin Microbiol Infect. 2020 Feb;26(2):255.e1-255.e6. doi: 10.1016/j.cmi.2019.02.009. Epub 2019 Feb 22.
7
Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.预防心律失常装置感染试验:PADIT 试验。
J Am Coll Cardiol. 2018 Dec 18;72(24):3098-3109. doi: 10.1016/j.jacc.2018.09.068.
8
Cardiac implantable electronic device infections: Who is at greatest risk?心脏植入式电子设备感染:谁的风险最大?
Heart Rhythm. 2017 Jun;14(6):839-845. doi: 10.1016/j.hrthm.2017.03.019. Epub 2017 Mar 16.
9
Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT).全球随机抗生素包膜感染预防试验(WRAP-IT)
Am Heart J. 2016 Oct;180:12-21. doi: 10.1016/j.ahj.2016.06.010. Epub 2016 Jun 23.
10
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.心脏植入式电子设备感染的危险因素:一项系统评价和荟萃分析。
Europace. 2015 May;17(5):767-77. doi: 10.1093/europace/euv053.